search
Login Form

Collection of referred small molecules with carefully collected activity data

2 405 compounds

To address continuously growing interested to Drug Repurposing we designed and carefully collected a Bioactive Reference Collection of over 2 400 compounds with extensive target classes’ coverage and the broadest possible therapeutic areas applications – from CNS agents and anti-infectives to anticancer drugs and steroids.

Represented collection of carefully selected compounds includes 1 123 FDA approved drugs, as well as “tool compounds” with validated biological activity, active metabolites/prodrugs, and drug candidates that are currently undergoing clinical trials.

Download SD files

Bioreference Compound Library

Library code: BRL-2405

Version: 13 November 2023

2 405 compounds

FDA approved drugs

Library code: FAD-1123

Version: 9 November 2023

1 123 compounds

sublibrary of Bioreference Library

Bioactive Compounds

Library code: BAC-1282

Version: 14 November 2023

1 282 compounds

sublibrary of Bioreference Library

Ready-to-use, fully referred, alternative for compound screening.

Any compound from BRC collection can be ordered individually as focused sets: target-based or by therapeutic area.

Proven and reliable

  • Stringent quality control using most advanced methods.
  • Synthetic chemistry capacity with professionals in organic chemistry experienced in diverse synthetic methods and techniques.
  • Drugs synthesis and their functional modifications for target identification and other purposes.

Distribution of compounds by therapeutic area

Distribution of compounds by therapeutic area

Related products & services

Target identification toolbox

Additionally we provide broad functionalization of Drugs and relative actives with covalent warheads, biotin or/and dye-linking, PED-derivatization and other modifications. Versatile chemistry and the largest stock of valuable reagents enables Enamine to produce new functionalization of well-known drugs.

We combined most diverse approaches and possible structural modifications to achieve most complete representation of our Target identification tools.

 

Contact Us